When Actavis ($ACT) and Watson Pharmaceuticals merged last year, top managers warned that layoffs and shutdowns would follow. Now, Actavis says it's planning to close a plant in North Carolina--and cut 310 jobs in the process. Report
When Actavis ($ACT) and Watson Pharmaceuticals merged last year, top managers warned that layoffs and shutdowns would follow. Now, Actavis says it's planning to close a plant in North Carolina--and cut 310 jobs in the process. Report